2026-01-29 - Analysis Report
**Accenture (ACN) Financial Report**

### Comparison with S&P 500 (VOO)

* Cumulative return of review stock: 50.46%
* Cumulative return of comparison stock (S&P 500, VOO): 128.51%
* Divergence (max: 86.50, min: -92.20, current: -78.00, relative divergence: 7.90%)

### Company Overview

Accenture is a global management consulting, technology services, and outsourcing company.

### Alpha, Beta Analysis

| Year     | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|----------|-------|-------|-------|-------|--------|
| 2016-2018 | 12.0% | 19.8% | 3.0% | 1.1 | 85.8B  |
| 2017-2019 | 56.0% | 19.8% | 31.0% | 1.1 | 128.1B |
| 2018-2020 | 47.0% | 32.3% | 23.0% | 1.0 | 158.9B |
| 2019-2021 | 146.0% | 32.3% | 82.0% | 1.0 | 252.2B |
| 2020-2022 | 8.0%  | 34.3% | 3.0%  | 1.1 | 162.4B |
| 2021-2023 | 32.0% | 34.3% | 14.0% | 1.2 | 213.5B |
| 2022-2024 | -31.0%| 25.8% | -60.0%| 1.1 | 214.1B |
| 2023-2025 | -23.0%| 38.9% | -98.0%| 0.9 | 163.2B |

### Recent Stock Price Fluctuations

* Close: $275.80
* Last-market: $270.655 (previous close: $275.8, change: -1.87%)
* 5-day SMA: $280.67
* 20-day SMA: $277.12
* 60-day SMA: $263.71

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): 0.70 (0.9~1.0: High Investment Recommended, 0.7~0.9: Medium Investment, 0.4~0.7: Low Investment, <0.4: Very Risky)
* RSI: 49.90
* PPO: -0.32
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -2.30 (-): worsening
* 7-day Rank change: 57 (+): rank up
* 7-day Dynamic Expected Return change: 275.60 (+): improving
* Expected Return (%): 102.60%, Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

### Recent News & Significant Events

* [2026-01-28] John Walsh Sells 3,986 Shares of Accenture (NYSE:ACN) Stock - MarketBeat
* [2026-01-28] Insider Sale: Chief Leadership & HR Officer of $ACN Sells 514 Shares - Quiver Quantitative
* [2026-01-28] Here is What to Know Beyond Why Accenture PLC (ACN) is a Trending Stock - Yahoo Finance Singapore
* [2026-01-28] Automatic Data Processing Q2 Earnings Top Estimates, Revenues Rise Y/Y - The Globe and Mail
* [2026-01-26] Why Accenture (ACN) is a Top Momentum Stock for the Long-Term - Nasdaq
* [2026-01-27] Wells Fargo Sees Stable 2026 Demand for Accenture (ACN), with AI as a Tailwind - Finviz

### Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.04 (~Buy)
- Opinions: 27
- Target Price (avg/high/low): 291.98 / 330.00 / 210.00

### Recent Earnings Analysis

| Date | EPS | Revenue |
|-----|-----|-------|
| 2025-12-18 | 3.57 | $18.74B |
| 2025-10-10 | 2.27 | $17.60B |
| 2025-06-20 | 3.52 | $17.73B |
| 2025-03-20 | 2.85 | $16.66B |

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $18.74B | 33.07% |
| 2025-08-31 | $17.60B | 31.89% |
| 2025-05-31 | $17.73B | 32.87% |
| 2025-02-28 | $16.66B | 29.86% |
| 2024-11-30 | $17.69B | 32.92% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $30.87B | 7.16% |
| 2025-08-31 | $31.20B | 4.53% |
| 2025-05-31 | $30.55B | 7.19% |
| 2025-02-28 | $29.25B | 6.11% |
| 2024-11-30 | $29.19B | 7.81% |

### Comprehensive Analysis

Accenture's cumulative return has been significantly lower than that of the S&P 500. However, its Alpha and Beta values show relatively stable performance. The company's recent stock price has been experiencing fluctuations, with a 5-day SMA of $280.67 and a 20-day SMA of $277.12.

The RSI and PPO indicators show a neutral signal, while the hybrid signal is Buy. The market risk indicator is at 0.70, indicating a medium investment risk level.

Recent news and significant events suggest a stable demand for Accenture's services, with AI being a key growth driver.

Analyst consensus is positive, with 27 opinions and a mean rating of 2.04, indicating a BUY rating. The target price is estimated to be around $291.98.

The recent earnings analysis shows a stable revenue growth, with an average annual revenue of $18.45B. The profit margin has been steadily increasing, with an average annual profit margin of 31.65%.

The capital and profitability analysis shows a stable equity value, with an average annual equity of $30.44B. The return on equity (ROE) has been fluctuating, with an average annual ROE of 6.43%.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.